Nika Pharmaceuticals, Inc - Apr 13, 2022 Form 4 Insider Report for NIKA PHARMACEUTICALS, INC (NKPH)

Role
President, CEO, CFO, Director, 10%+ Owner
Signature
Savov Dimitar Slavchev
Stock symbol
NKPH
Transactions as of
Apr 13, 2022
Transactions value $
$29,999,999,727,868
Form type
4
Date filed
3/19/2024, 02:08 PM
Next filing
Mar 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKPH Preferred A Stock Other $30T +10M $3,000,000.00* 10M Apr 13, 2022 Direct F1, F2
transaction NKPH Common Purchase $138K +11.5M $0.01* $11.5M Apr 13, 2022 Direct
transaction NKPH Common Other $0 +333M $0.00 $345M Jul 20, 2022 Direct F3
transaction NKPH Common Sale -$140K -7M $0.02* $338M Sep 12, 2022 Direct
transaction NKPH Common Sale -$25K -1.25M $0.02* $336M Sep 26, 2022 Direct
transaction NKPH Common Sale -$111K -3M $0.04* $333M Oct 24, 2022 Direct
transaction NKPH Common Sale -$63K -6.3M $0.01* $327M Jan 10, 2023 Direct
transaction NKPH Common Sale -$15K -1.5M $0.01* $326M Jan 31, 2023 Direct
transaction NKPH Common Sale -$56K -3.5M $0.02* $322M Jun 2, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issuance per terms of Exclusive Rights Agreement
F2 Exclusive rights valued at 3,000,000
F3 30-1 forward split as dividend